Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2022
The upper ECHELON against T-cell lymphoma
E Bachy, G Salles
QJM : Monthly Journal of the Association of Physicians
|
February 10, 2015
Sarcoidosis and lymphoma: a comparative study
É Chalayer, E Bachy, P Occelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
From hepatitis C virus infection to B-cell lymphoma
L Couronné, E Bachy, S Roulland, et al.
Hematological Oncology
|
July 6, 2016
Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients
F Tixier, F Ranchon, A Iltis, et al.
Immuno-Oncology Technology
|
January 8, 2026
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial)
N Alshatti, F Lemonnier, E Bachy, et al.
Journal of Cancer Research and Clinical Oncology
|
June 18, 2021
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
V Leclerc, L Karlin, C Herledan, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
January 15, 2025
Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering
O Hequet, V Mialou, F Cognasse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
N Mounier, P Brice, S Bologna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2023
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
A S Cottereau, L Rebaud, J Trotman, et al.
Bone Marrow Transplantation
|
September 20, 2016
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
E Van Den Neste, N Schmitz, N Mounier, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2022
The upper ECHELON against T-cell lymphoma
E Bachy, G Salles
QJM : Monthly Journal of the Association of Physicians
|
February 10, 2015
Sarcoidosis and lymphoma: a comparative study
É Chalayer, E Bachy, P Occelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
From hepatitis C virus infection to B-cell lymphoma
L Couronné, E Bachy, S Roulland, et al.
Hematological Oncology
|
July 6, 2016
Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients
F Tixier, F Ranchon, A Iltis, et al.
Immuno-Oncology Technology
|
January 8, 2026
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial)
N Alshatti, F Lemonnier, E Bachy, et al.
Journal of Cancer Research and Clinical Oncology
|
June 18, 2021
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
V Leclerc, L Karlin, C Herledan, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
January 15, 2025
Simple method to predict lymphocyte collection for chimeric antigen receptor T-cell engineering
O Hequet, V Mialou, F Cognasse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
N Mounier, P Brice, S Bologna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2023
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
A S Cottereau, L Rebaud, J Trotman, et al.
Bone Marrow Transplantation
|
September 20, 2016
Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study
E Van Den Neste, N Schmitz, N Mounier, et al.
Page
of 2